{
    "Symbol": "TECH",
    "AssetType": "Common Stock",
    "Name": "Bio-Techne Corp",
    "Description": "Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.",
    "CIK": "842023",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)",
    "Address": "614 MCKINLEY PL N E, MINNEAPOLIS, MN, US",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "12977124000",
    "EBITDA": "326299000",
    "PERatio": "65.88",
    "PEGRatio": "1.148",
    "BookValue": "12.79",
    "DividendPerShare": "0.32",
    "DividendYield": "0.0039",
    "EPS": "1.25",
    "RevenuePerShareTTM": "7.32",
    "ProfitMargin": "0.176",
    "OperatingMarginTTM": "0.237",
    "ReturnOnAssetsTTM": "0.0611",
    "ReturnOnEquityTTM": "0.104",
    "RevenueTTM": "1154281000",
    "GrossProfitTTM": "770215000",
    "DilutedEPSTTM": "1.25",
    "QuarterlyEarningsGrowthYOY": "-0.279",
    "QuarterlyRevenueGrowthYOY": "0.032",
    "AnalystTargetPrice": "83.86",
    "AnalystRatingStrongBuy": "5",
    "AnalystRatingBuy": "5",
    "AnalystRatingHold": "4",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "65.88",
    "ForwardPE": "33.67",
    "PriceToSalesRatioTTM": "9.16",
    "PriceToBookRatio": "5.34",
    "EVToRevenue": "9.53",
    "EVToEBITDA": "29.02",
    "Beta": "1.289",
    "52WeekHigh": "85.57",
    "52WeekLow": "51.61",
    "50DayMovingAverage": "76.65",
    "200DayMovingAverage": "71.15",
    "SharesOutstanding": "157585000",
    "DividendDate": "2024-05-24",
    "ExDividendDate": "2024-05-10"
}